Acetonitrile, (hexyloxy)-
Common Name: |
Acetonitrile, (hexyloxy)- |
IUPAC Name: |
2-hexoxyacetonitrile |
Molecular Formula: |
C12H18O3 |
SMILES: |
CCCCCCOCC#N |
Inchi: |
1S/C8H15NO/c1-2-3-4-5-7-10-8-6-9/h2-5,7-8H2,1H3 |
Inchi Key: |
VEAMDGDGVPXWDQ-UHFFFAOYSA-N |
Cas No: |
66912-24-1 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
0 |
Name |
Value |
Molecular Weight (g/mol) |
210.27 |
Mass (g/mol) |
141.115 |
Molar Refractivity |
60.24 |
Net Charge |
|
HBD |
1 |
HBA |
3 |
Rt Bonds |
6 |
Rings |
|
TPSA |
38.69 |
Hetero Atoms |
2 |
Heavy Atoms |
15 |
Aromatic Heavy Atoms |
6 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
203.00 to 204.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.281 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.50 |
LogP |
2.107 |
iLOGP |
2.94 |
XLOGP3 |
1.77 |
WLOGP |
2.57 |
MLOGP |
1.79 |
ESOL Log S |
-2.16 |
ESOL Solubility (mg/ml) |
1.46 |
ESOL Solubility (mol/l) |
0.007 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-2.20 |
Ali Solubility (mg/ml) |
1.33 |
Ali Solubility (mol/l) |
0.01 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-3.70 |
Silicos-IT Solubility (mg/ml) |
0.04 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-6.33 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.734 |
CYP1A2 Inhibitor |
1 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
1 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.565 |
Carcinogenicity (Binary) |
1 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |